Jean-Pierre Bizzari insider trades

Open-market stock purchases and sales by Jean-Pierre Bizzari, Director at Aprea Therapeutics, Inc, from SEC Form 4 filings since Jan 17, 2015.

Recent trades

DateStockTradeValue
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jun 16, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jun 3, 2026ADCT ADC Therapeutics SASold (not open market)$38.8K
Jun 1, 2026ADCT ADC Therapeutics SABought (not open market)—

Companies traded

  • APRE Aprea Therapeutics, Inc: other filings, last Jun 16, 2026
  • ADCT ADC Therapeutics SA: 1 sale, last Jun 3, 2026
  • HALO Halozyme Therapeutics, Inc: 1 sale, last May 5, 2023
  • PIRS Pieris Pharmaceuticals, Inc: other filings, last Jan 25, 2020
  • CPXX Celator Pharmaceuticals Inc: other filings, last Jul 12, 2016

Get free alerts when Jean-Pierre Bizzari files a new trade →